Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin

Lasers in Surgery and Medicine - Tập 39 Số 3 - Trang 203-209 - 2007
Cristina Zane1, Rossana Capezzera2, Raffaella Sala2, Marina Venturini2, Piergiacomo Calzavara‐Pinton2
1Department of Dermatology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
2Department of Dermatology, Spedali Civili Hospital and University of Brescia, Brescia, Italy

Tóm tắt

AbstractBackground and ObjectivePhotodynamic therapy (PDT) using aminolevulinic acid (ALA) has been previously investigated in the treatment of photodamaged skin. The aim was to assess efficacy and tolerability of methylaminolevulinate (MAL) as a substitute for ALA in PDT treatment of actinic keratosis (AK) and photoaging.Study Design/Materials and MethodsTwenty patients with multiple (n = 137) AKs and severe photodamage of the face were treated. Metvix® (Galderma, France) was applied under occlusion for 3 hours before exposure to 37 J/cm2 of red light (Aklilite® CL 128, Photocure, Norway). Two treatments were given at monthly intervals.ResultsThe clearance rate of AKs was 88.3%, and global score which we use to rate photoaging, mottled hyperpigmentation, fine lines, roughness, and sallowness of the skin showed improvement, but deep wrinkles, teleangiectasia, facial erythema, and sebaceous gland hypertrophy did not change. The treatments were well tolerated. High‐resolution echography showed an increase in skin thickness, pixels count and area, as well as a reduction of the subepidermal low‐echogenic band (SLEB) thickness.ConclusionMAL‐PDT is an effective treatment for multiple AKs. In addition, it improves clinical signs of photodamage of the surrounding skin. Lasers Surg. Med. 39:203–209, 2007. © 2007 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.2165/00128071-200001020-00009

10.1067/mjd.2002.119649

10.1016/0304-3959(83)90126-4

10.1001/archderm.141.10.1247

Pellacani G, 1999, Variations in facial skin thickness and echogenicity with site and age, Acta Derm Venereol (Stockh), 79, 1

Goldman MP, 2002, PDT/ALA in the treatment of actinic damage: Real world experience, J Lasers Med Surg, 14, S24

Gold MH, 2003, Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy, J Lasers Med Surg, 15, S47

10.1111/j.1524-4725.2004.30331.x

10.1001/archderm.140.1.33

Avram DK, 2004, Effectiveness and safety of ALA‐IPL in treating actinic keratoses and photodamage, J Drugs Dermatol, 3, S38

Key DJ, 2005, Aminolevulinic acid pulsed dye laser photodynamic therapy for the treatment of photoaging, Cosmetic Dermatol, 18, 31

10.1001/archfaci.6.6.374

10.1001/archderm.1995.01690180071013

10.1046/j.1524-4725.2002.02018.x

10.1001/archderm.139.10.1313

10.1080/14764170500344179

Gaullier JM, 1997, Use of 5‐aminolevulinic acid esters to improve photodynamic therapy on cells in culture, Cancer Res, 57, 1481

10.1016/1011-1344(95)07268-3

10.1080/14764170500370059

10.1001/archderm.139.9.1173

10.1111/j.1751-1097.1998.tb02492.x

10.1038/sj.jid.5700207

10.1038/sj.jid.5700048

10.1055/s-2005-872411

10.1111/j.1365-2133.2004.06209.x

10.1039/b514128a

Gold MH, 2004, Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5‐aminolevulinic acid and a blue light source or intense pulsed light source, J Drugs Dermatol, 3, S6

10.1001/archderm.142.6.781

10.1111/j.1751-1097.1997.tb03178.x

10.1007/s00403-002-0320-4

10.1080/00015550510042868

10.1038/sj.jid.5700098